Clinical Trial Update: Effect of Lorcaserin on Cannabis Withdrawal and Self-administration [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating lorcaserin's effects on cannabis withdrawal and self-administration has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Lorcaserin (lorcaserin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Use | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-07-26